Cargando…
Personalized Medicine in Cardiovascular Diseases
Personalized medicine is a novel medical model with all decisions and practices being tailored to individual patients in whatever ways possible. In the era of genomics, personalized medicine combines the genetic information for additional benefit in preventive and therapeutic strategies. Personalize...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467440/ https://www.ncbi.nlm.nih.gov/pubmed/23091501 http://dx.doi.org/10.4070/kcj.2012.42.9.583 |
_version_ | 1782245804222709760 |
---|---|
author | Lee, Moo-Sik Flammer, Andreas J. Lerman, Lilach O. Lerman, Amir |
author_facet | Lee, Moo-Sik Flammer, Andreas J. Lerman, Lilach O. Lerman, Amir |
author_sort | Lee, Moo-Sik |
collection | PubMed |
description | Personalized medicine is a novel medical model with all decisions and practices being tailored to individual patients in whatever ways possible. In the era of genomics, personalized medicine combines the genetic information for additional benefit in preventive and therapeutic strategies. Personalized medicine may allow the physician to provide a better therapy for patients in terms of efficiency, safety and treatment length to reduce the associated costs. There was a remarkable growth in scientific publication on personalized medicine within the past few years in the cardiovascular field. However, so far, only very few cardiologists in the USA are incorporating personalized medicine into clinical treatment. We review the concepts, strengths, limitations and challenges of personalized medicine with a particular focus on cardiovascular diseases (CVDs). There are many challenges from both scientific and policy perspectives to personalized medicine, which can overcome them by comprehensive concept and understanding, clinical application, and evidence based practices. Individualized medicine serves a pivotal role in the evolution of national and global healthcare reform, especially, in the CVDs fields. Ultimately, personalized medicine will affect the entire landscape of health care system in the near future. |
format | Online Article Text |
id | pubmed-3467440 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | The Korean Society of Cardiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-34674402012-10-22 Personalized Medicine in Cardiovascular Diseases Lee, Moo-Sik Flammer, Andreas J. Lerman, Lilach O. Lerman, Amir Korean Circ J Review Personalized medicine is a novel medical model with all decisions and practices being tailored to individual patients in whatever ways possible. In the era of genomics, personalized medicine combines the genetic information for additional benefit in preventive and therapeutic strategies. Personalized medicine may allow the physician to provide a better therapy for patients in terms of efficiency, safety and treatment length to reduce the associated costs. There was a remarkable growth in scientific publication on personalized medicine within the past few years in the cardiovascular field. However, so far, only very few cardiologists in the USA are incorporating personalized medicine into clinical treatment. We review the concepts, strengths, limitations and challenges of personalized medicine with a particular focus on cardiovascular diseases (CVDs). There are many challenges from both scientific and policy perspectives to personalized medicine, which can overcome them by comprehensive concept and understanding, clinical application, and evidence based practices. Individualized medicine serves a pivotal role in the evolution of national and global healthcare reform, especially, in the CVDs fields. Ultimately, personalized medicine will affect the entire landscape of health care system in the near future. The Korean Society of Cardiology 2012-09 2012-09-27 /pmc/articles/PMC3467440/ /pubmed/23091501 http://dx.doi.org/10.4070/kcj.2012.42.9.583 Text en Copyright © 2012 The Korean Society of Cardiology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Lee, Moo-Sik Flammer, Andreas J. Lerman, Lilach O. Lerman, Amir Personalized Medicine in Cardiovascular Diseases |
title | Personalized Medicine in Cardiovascular Diseases |
title_full | Personalized Medicine in Cardiovascular Diseases |
title_fullStr | Personalized Medicine in Cardiovascular Diseases |
title_full_unstemmed | Personalized Medicine in Cardiovascular Diseases |
title_short | Personalized Medicine in Cardiovascular Diseases |
title_sort | personalized medicine in cardiovascular diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467440/ https://www.ncbi.nlm.nih.gov/pubmed/23091501 http://dx.doi.org/10.4070/kcj.2012.42.9.583 |
work_keys_str_mv | AT leemoosik personalizedmedicineincardiovasculardiseases AT flammerandreasj personalizedmedicineincardiovasculardiseases AT lermanlilacho personalizedmedicineincardiovasculardiseases AT lermanamir personalizedmedicineincardiovasculardiseases |